Bill Information for s832-119

Long Title

A bill to amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Short Title

Ensuring Pathways to Innovative Cures Act of 2025

Vote Information

Status: REFERRED as of 2025-03-04 00:00:00.

Sponsor: This bill was sponsored by Thom Tillis (R-NC).

Party line votes are determined based on this being a R-sponsored piece of legislation. See here for information on how party line votes are determined.

Vote count: There were 0 roll call votes on this bill in total.